Serum prohepcidin levels in children with solid tumors, inflammatory bowel disease and iron deficiency anemia

Journal of Tropical Pediatrics

Volumn 57, Issue 2, 2011, Pages 120-125

  Kaya, Zühre ^a   Yildiz, Ejderhan ^b   Gursel, Turkiz ^a   Albayrak, Meryem ^a   Kocak, Ulker ^a   Karadeniz, Ceyda ^a   Dalgiç, Buket ^a  

^a GAZI UNIVERSITY   (Turkey)

^b 29 Mayis Hospital   (Turkey)

Author keywords

Children; Inflammatory bowel disease; Iron deficiency anemia; Prohepcidin; Solid tumors

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; HEMOGLOBIN; IRON; PROHEPCIDIN; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENTERITIS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; MALE; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SOLID TUMOR;

EID: 79953744352     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmq058     Document Type: Article

References (30)

1. Atanasiu V, Manolescu B, Stoian I. Prohepcidin-central regulator of iron metabolism. Eur J Haematol 2007;78:1-10.
2. Lee PL, Beutler E. Regulation of prohepcidin and ironoverload disease. Annu Rev Pathol 2009;4:489-515.
3. Nemeth E, Valore EV, Territo M, et al. Prohepcidin, a putative mediator of anemia of inflammation, is a type II acute phase protein. Blood 2003;101:2461-3.
4. Weiss G. Iron metabolism in the anemia of chronic disease. Biochim Biophys Acta 2009;1790:682-93.
5. Fleming RE. Iron and inflammation: cross talk between pathways regulating hepcidin. J Mol Med 2008;86:491-4.
6. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003;102:783-8.
7. Gasche C, Lomer MCE, Cavill I, et al. Iron, anaemia, and inflammatory bowel diseases. Gut 2004;53:1190-7.
8. Arnold J, Sangwaiya A, Bhatkal B, et al. Prohepcidin and inflammatory bowel disease: dual role in host defence and iron homoeostasis. Eur J Gastroenterol Hepatol 2009;21:425-9.
9. Jacober ML, Mamoni RL, Lima CS, et al. Anaemia in patients with cancer: role of inflammatory activity on iron metabolism and severity of anaemia. Med Oncol 2007;24:323-9.
10. Jayaranee S, Sthaneshwar P, Sokkalingam S. Serum prohepcidin concentrations in rheumatoid arthritis. Pathology 2009;41:178-82.
11. Demirag MD, Haznedaroglu S, Sancak B, et al. Circulating prohepcidin in the crossroads of anemia and inflammation associated with rheumatoid arthritis. Intern Med 2009;48:421-6.
12. Andrews NC. Anemia of inflammation: the cytokinehepcidin link. J Clin Invest 2004;113:1251-3.
13. Darshan D, Anderson GJ. Interacting signals in the control of hepcidin expression. Biometals 2009;22: 77-87.
14. Kemna E, Pickkers P, Nemeth E, et al. Time course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 2005;106:1864-6.
15. Semrin G, Fishman DS, Bousvaros A, et al. Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation. Inflamm Bowel Dis 2006;12:1101-6.
16. Lou DQ, Lesbordes JC, Nicolas G, et al. Iron and inflammation-induced hepcidin gene expression in mice is not mediated by Kupffer cells in vivo. Hepatology 2005;41:1056-64.
17. Nicolas G, Bennoun M, Porteu A, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 2002;99:4596-601.
18. Cherian S, Forbes DA, Cook AG, et al. An insight into the relationships between hepcidin, anemia, infections and inflammatory cytokines in pediatric refugees: a cross sectional study. PLoS One 2008;3:4030-3.
19. Orhon FS, Ulukol B, Hanoluk A, et al. Serum prohepcidin levels in infants with iron deficiency anaemia. Int J Lab Hem 2008;30:546-7.
20. Cook JD, Finch CA. Assessing iron status of a population. Am J Clin Nutr 1979;32:2115-9.
21. Abshire TC, Reeves JD. Anemia of inflammation in children. J Pediatr 1983;103:868-71.
22. Lopez MAV, Molinos FL, Carmona ML, et al. Serum transferrin receptor in children: Usefulness for determinating the nature of anemia in infection. J Pediatr Hematol Oncol 2006;28:809-15.
23. Vilk SR, Tamary H, Broide E, et al. Serum transferrin receptor in children and adolescents with inflammatory bowel disease. Eur J Pediatr 2000;159:585-9.
24. Dimitriou H, Stiakaki E, Markaki EA, et al. Soluble transferrin receptor levels and soluble transferrin receptor/log ferritin index in the evaluation of erythropoietic status in childhood infections and malignancy. Acta Paediatr 2000;89:1169-73.
25. Chua E, Claque JE, Sharma AK, et al. Serum transferrin receptor assay in iron deficiency anemia and anemia of chronic disease in the elderly. Q J Med 1999;92:587-94.
26. Jacober MLV, Mamoni RL, Lima CSP, et al. Anemia in patients with cancer: role of inflammatory activity on iron metabolism and severity of anemia. Med Oncol 2007;24:323-9.
27. Grotto HZW. Anemia of cancer: an overview of mechanisms involved in its pathogenesis. Med Oncol 2008;25:12-21.
28. Corazza F, Beguin Y, Bergmann P, et al. Anemia in children with cancer is associated with decreased erythropoietic activity and not with inadequate erythropoietin production. Blood 1998;92:1793-8.
29. Kamai T, Tomosugi N, Abe H, et al. Increased serum hepcidin-25 level and increased tumor expression of hepcidin mRNA are associated with metastasis of renal cell carcinoma. BMC Cancer 2009;9:270-9.
30. Ward DG, Roberts K, Brookes MJ, et al. Increased hepcidin expression in colorectal carcinogenesis. World J Gastroenterol 2008;14:1339-45.